Evidence map›Paper›PMID 42501190›Full record

ArticleMedical & biological engineering & computing2026

AV-NeXt: a topology-aware framework with interaction modeling and competitive gating for retinal artery/vein segmentation.

Mingyang Sun, Xiaoyang He

Abstract read
PubMed Publisher
In one paragraph

Article in Medical & biological engineering & computing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mingyang SunSchool of Information Science and Engineering, Dalian Polytechnic University, Qinggongyuan 1, Ganjingzi District, Liaoning, 116034, Dalian, China.
Xiaoyang HeSchool of Information Science and Engineering, Dalian Polytechnic University, Qinggongyuan 1, Ganjingzi District, Liaoning, 116034, Dalian, China. Hexy20260127@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Automated segmentation and classification of retinal arteries and veins (A/V) are pivotal for the precise morphological characterization required in the early diagnosis of systemic cardiovascular and ophthalmic pathologies. However, existing deep learning paradigms exhibit limitations in resolving complex structural entanglement at A/V crossings, frequently resulting in vascular disconnection and classification ambiguity due to the insufficient modeling of local artery-vein interactions. To address these challenges, AV-NeXt, a topology-aware framework, is proposed to improve crossing-region recognition by integrating anatomically motivated A/V interaction modeling into deep feature representations. Constructed upon a ConvNeXt backbone, the framework incorporates two pivotal components: (1) an Interaction-conditioned Crossing Head, which exploits feature-level co-activation cues between artery and vein streams to assist crossing prediction; and (2) a Competitive Gating Mechanism, designed to dynamically reduce crossing-induced classification ambiguity through soft gating. Extensive experiments on Fundus-AVSeg demonstrated that AV-NeXt achieved the best overall performance among the compared methods, with an mDice of 76.72%, an mIoU of 63.64%, and a Crossing IoU of 44.85%. Paired statistical analysis further supported the reliability of the crossing-region gains, while zero-shot evaluation on RITE showed competitive crossing recognition under domain shift, with a Crossing IoU of 28.52%.

Indexed as

Image Processing, Computer-AssistedRetinal ArteryRetinal VeinAlgorithmsDeep LearningHumansConvNeXtMedical image analysisRetinal artery/vein segmentationTopology-aware learningZero-shot generalization

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.